ASSESSMENT OF MAGNESIUM (MG) AND ZINC (ZN) IN CARCINOMA BREAST PATIENTS

Authors

  • NEERAJ SINGH SONGARA Department of Biochemistry, Jhalawar Medical College, Jhalawar, Rajasthan, India.
  • AJAY KUMAR BHARGAVA Department of Biochemistry, Jhalawar Medical College, Jhalawar, Rajasthan, India.
  • AKSHITA CHAUDHARY Department of Biochemistry, Jhalawar Medical College, Jhalawar, Rajasthan, India.
  • ANUSHREE SHARMA Department of Biochemistry, Jhalawar Medical College, Jhalawar, Rajasthan, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i10.45486

Keywords:

Breast carcinoma, Trace elements, Atomic absorption spectrophotometry

Abstract

Objectives: The objectives of the study were to determine and compare serum magnesium (Mg) and zinc (Zn) concentrations between breast carcinoma patients and healthy controls.

Methods: Determination and comparison of serum Mg and Zn was done between 50 breast carcinoma patients and 50 healthy controls. Determination and comparison of LFT in between 50 breast cancer patient during different course of chemotherapy. Trace element analysis was done using atomic absorption spectrophotometry. Statistical comparison was done, results were expressed as Mean±SD, p<0.05 was considered to be statistically significant.

Results: All groups were statistically matched in age, sex, and p>0.05. Serum Mg concentrations in cases and controls (0.9920±0.38 mg/dL) and (1.49±0.58 mg/dL) respectively, p≤0.0001* serum Zn concentrations in cases and controls were (66.74±12.58 μg/dL) and (90.88±14.51 μg/dL), respectively, p≤0.0001*.

Conclusion: Both serum (Zn) and (Mg) showed significant decreases in breast carcinoma patients as compare to healthy controls.

Downloads

Download data is not yet available.

References

Parkeh DM, Piscani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Intl J Cancer 1999;80:827-41.

Bailey and Love short practice of surgery 27:871.

Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin. 2005;55:74-108.

Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan KL, Santhappan S, et al. Cancer Stastistics 2020: Report from national cancer registry program, India. JCO Glob Oncol 2020;6:1063-75.

SRB’s Manual of Surgery 3;467.

De Bont R, van Larebeke N. Endogenous DNA damage in humans: A review of quantitative data. Mutagenesis 2004;19:169-85.

Chakrabarti SK, Bai C, Subramanian KS. DNA-protein cross links induced by nickel compounds in isolated rat lymphocytes, role of reactive oxygen species and specific amino acids. Toxicol Appl Pharmacol 2001;170:153-65.

Frenkel K. Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol Ther 1992;53:127-66.

Girotti AW, Thomas JP. Damaging effects of oxygen radicals on resealed erythrocyte ghosts. J Biol Chem 1984;259:1744-52.

Halliwell B, Aruoma OI. DNA damage by oxygen-derived species. FEBS Lett 1991;281:9-19.

Stoica A, Pentecost E, Martin MB. Effects of arsenite on estrogen receptor-alpha expression and activity in MCF-7 breast cancer cells. Endocrinology 2000;141:3595-602.

Garcia-Morales P, Saceda M, Kenney N, Kim N, Salomon DS, Gottardis MM, et al. Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem 1994;269:16896-901.

Stoica A, Katzenellenbogen BS, Martin MB. Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol Endocrinol 2000;14:545-53.

International Agency for Research on Cancer (IARC). Overall Evaluation of Carcinogenicity, Lead Compounds, Organic. Vol. 23. France: International Agency for Research on Cancer; 2006. p. 87.

Ostrakhovitch EA, Cherian MG. Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells. Apoptosis 2005;10:111-21.

Adebamowo CA, Hu FB, Cho E, Spiegelman D, Holmes MD, Willett WC. Dietary patterns and the risk of breast cancer. Ann Epidemiol 2005;15:789-95.

Atoe K, Idemudia JO, Eboreime O. Serum magnesium level in women with breast cancer in Benin city, Nigeria. Int J Trop Dis Health 2014;4:723-8.

Pavithra V, Sathisha TG, Kasturi K, Siva Mallika D, Jeevan Amos S, Ragunatha S. Serum levels of metal ions in female patients with breast cancer. J Clin Diagn Res 2015;9:BC25-7.

Schrauzer GN. The role of trace elements in the etiology of cancer. Trace Elem Anal Chem Med Biol 1980;171:183-98.

Blondell JW. The anti cancer effect of magnesium. Med Hypothesis 1980;6:863-71.

Koolman J, Roehm KH. Color Atlas of Biocheistry. 2nd ed. Stuttgart: Thieme Stuttgart; 2005. p. 362.

Hassan T, Queshi W, Bhat SA, Majid S, Mir MU, Shrivastava P, et al. Study of serum levels of trace elements (selenium, copper, zinc and iron) in breast cancer. Int J Clin Oncol Cancer Res 2017;2:82-5.

Adeoti ML, Oguntola AS, Akanni EO, Agodirin OS, Oyeyemi GM. Trace elements; copper, zinc and selenium, in breast cancer afflicted female patients in LAUTECH Osogbo, Nigeria. Indian J Cancer 2015;52:106-9.

Murakami M, Hirano T. Intracellular zinc homeostasis and zinc signaling. Cancer Sci 2008;99:1515-22.

John E, Laskow TC, Buchser WJ, Pitt BR, Basse PH, Butterfield LH, et al. Zinc in innate and adaptive tumor immunity. J Transl Med 2010;8:118.

Tapiero H, Tew KD. Trace elements in human physiology and pathology: Zinc and metallothioneins. Biomed Pharmacother 2003;57:399-411.

Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, et al. Association of screening and treatment with breast cancer mortality by molecular subtype in US Women, 2000-2012. JAMA 2018;319:154-64.

Published

07-10-2022

How to Cite

SONGARA, N. S., A. K. BHARGAVA, A. CHAUDHARY, and A. SHARMA. “ASSESSMENT OF MAGNESIUM (MG) AND ZINC (ZN) IN CARCINOMA BREAST PATIENTS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 10, Oct. 2022, pp. 159-62, doi:10.22159/ajpcr.2022.v15i10.45486.

Issue

Section

Original Article(s)